Lilly and Innovent Announce Global Expansion of TYVYT Licensing Agreement
- Tuesday, August 18, 2020, 5:53
- Finance
- Add a comment
INDIANAPOLIS and SUZHOU, China, Aug. 18, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Innovent Biologics, Inc. (HKEX: 01801) today announced a global expansion of their strategic alliance for TYVYT® (sintilimab injection), an anti-PD-1 monoclonal antibody immuno-oncology…
About the Author
adminasapcorp has written 42172 stories on this site.